Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-08 · accession 0001367644-24-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-11 | 2024-06-08 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $6.19 | -1,249 | 163.1K | -0.8% | -$7,731 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-08 | F | D | 1,249 | $6.19 | 163,134 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |